GLP-1 diabetes drug neutral for the heart

15 Sept 2017


Extended-release exenatide (Bydureon) is safe for the heart but does not help prevent cardiovascular events in type 2 diabetes, a study published in the New England Journal of Medicine reports.

MedPage Today


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story